Sale!

FLCN Gene Pneumothorax Primary Spontaneous Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FLCN Gene Pneumothorax Primary Spontaneous Genetic Test is a specialized diagnostic procedure designed to identify mutations in the FLCN gene, which are associated with an increased risk of developing primary spontaneous pneumothorax (PSP). PSP is a condition characterized by the sudden onset of a collapsed lung without any apparent cause, which can lead to severe respiratory issues and requires immediate medical attention. The FLCN gene plays a crucial role in the regulation of cell growth and division, and mutations in this gene can disrupt normal lung tissue integrity, leading to PSP.

This genetic test is a valuable tool for individuals who have a family history of PSP or have experienced spontaneous pneumothorax themselves, as it can help in assessing their risk of developing the condition. Early detection of FLCN gene mutations allows for proactive monitoring and management of potential lung complications, significantly improving the quality of life for individuals at risk.

The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, which reflects the comprehensive analysis and personalized care provided with the service. Undergoing this test at DNA Labs UAE ensures access to state-of-the-art genetic testing technologies, expert interpretation of test results, and guidance on the next steps for individuals found to carry FLCN gene mutations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FLCN Gene Pneumothorax primary spontaneous Genetic Test

Welcome to DNA Labs UAE, where we offer the FLCN Gene Pneumothorax primary spontaneous Genetic Test. This test is designed to analyze the FLCN gene and detect mutations associated with Birt-Hogg-Dub syndrome (BHDS).

Test Components

  • FLCN Gene Pneumothorax primary spontaneous Genetic Test

Price

The cost of the test is 4400.0 AED.

Sample Condition

We accept blood, extracted DNA, or one drop of blood on an FTA card as sample conditions.

Report Delivery

You can expect to receive your test report within 3 to 4 weeks.

Method

We utilize NGS (Next-Generation Sequencing) technology for this genetic test.

Test Type

The FLCN Gene Pneumothorax primary spontaneous Genetic Test falls under the category of Ear Nose Throat Disorders.

Doctor

This test is typically recommended by ENT Doctors.

Test Department

Our Genetics department handles this particular test.

Pre Test Information

Prior to undergoing the IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS16.

Test Details

The FLCN gene is responsible for producing a protein called folliculin. Mutations in the FLCN gene are associated with Birt-Hogg-Dub syndrome (BHDS), a rare genetic disorder. BHDS is characterized by the development of multiple noncancerous tumors in the skin, lungs, and kidneys. One common manifestation of BHDS is primary spontaneous pneumothorax (PSP), which is the sudden collapse of a lung without any apparent cause. PSP can occur in individuals with BHDS due to lung cysts or blebs resulting from the FLCN gene mutation.

Our NGS genetic testing is a powerful tool that can analyze multiple genes simultaneously. It is particularly useful in identifying genetic mutations associated with various genetic disorders, including BHDS. By detecting mutations in the FLCN gene, NGS can provide valuable information for diagnosing BHDS and assessing the risk of developing associated complications such as PSP.

If an individual has a family history of BHDS or presents with symptoms suggestive of the condition, NGS genetic testing can be performed to identify mutations in the FLCN gene. This information can guide medical management, screening for associated tumors, and provide genetic counseling to affected individuals and their families.

Test Name FLCN Gene Pneumothorax primary spontaneous Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS16
Test Details

The FLCN gene is responsible for producing a protein called folliculin. Mutations in the FLCN gene are associated with a rare genetic disorder called Birt-Hogg-Dub syndrome (BHDS). BHDS is characterized by the development of multiple noncancerous tumors in the skin, lungs, and kidneys.

One of the common manifestations of BHDS is primary spontaneous pneumothorax (PSP), which is the sudden collapse of a lung without any apparent cause. PSP can occur in individuals with BHDS as a result of lung cysts or blebs that develop due to the FLCN gene mutation.

Next-generation sequencing (NGS) genetic testing is a type of genetic test that can analyze multiple genes simultaneously. It is a powerful tool for identifying genetic mutations associated with various genetic disorders, including BHDS. NGS can detect mutations in the FLCN gene and provide valuable information for diagnosing BHDS and assessing the risk of developing associated complications such as PSP.

If an individual has a family history of BHDS or presents with symptoms suggestive of the condition, NGS genetic testing can be performed to identify mutations in the FLCN gene. This information can help guide medical management, screening for associated tumors, and provide genetic counseling to affected individuals and their families.